Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc.
3 transactions — 0 achats et 3 ventes déclarés par les dirigeants de Impact BioMedical Inc..
7 fonds institutionnels déclarent une position sur IBO dans leur dernière déclaration trimestrielle SEC.
5 articles récents sur IBO.
Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.
Score composite sur 8 dimensions : insiders · hedge funds · politiciens · momentum · valorisation · sante · analystes · earnings.
Détection des achats ou ventes rapprochés de plusieurs dirigeants sur une même action.
Berkshire, Pershing Square, Tiger Global, Bridgewater et d’autres fonds déclarants.
NANC & GOP (Pelosi & republicains), GURU (top hedge funds), ARK (Cathie Wood). Voyez qui entre et sort chaque semaine.
Repérez les variations marquées de l’intérêt de recherche autour des actions suivies.
Créez votre watchlist et recevez un brief des événements sur vos tickers.
Cette page publique ne montre qu'un extrait. L'analyse complète de IBO sur le dashboard Kairos Insider inclut :
Inscription gratuite · Pro 19 €/mois ou 190 €/an